Aktuelle News
News Funktionen
Weitere Funktionen
27 März 2024
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
22 März 2024
Relief Therapeutics Holding SA
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
28 Februar 2024
Relief Therapeutics Holding SA
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
5 Dezember 2023
Relief Therapeutics Holding SA
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
22 November 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces CEO Transition
10 Oktober 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
15 September 2023
Relief Therapeutics Holding SA
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
1 September 2023
Relief Therapeutics Holding SA
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
30 August 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
19 Juli 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
23 Juni 2023
Relief Therapeutics Holding SA
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement
20 Juni 2023
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders
16 Juni 2023
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement
26 Mai 2023
Relief Therapeutics Holding SA
RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders
15 Mai 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory
12 Mai 2023
Relief Therapeutics Holding SA
Relief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
3 Mai 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
1 Mai 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
28 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
17 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
14 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
5 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Executive Leadership Team Change
4 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
3 April 2023
Relief Therapeutics Holding SA
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
22 März 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
17 März 2023
Relief Therapeutics Holding SA
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
16 März 2023
Relief Therapeutics Holding SA
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
15 März 2023
Relief Therapeutics Holding SA
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
28 Februar 2023
Relief Therapeutics Holding SA
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars